LFVN
Lifevantage·NASDAQ
--
--(--)
Market Open: --
--
--(--)
Pre-Market: --
Signals Analysis
Bullish signal 2
Bearish signal 1
Ample Liquidity
High Gross Profit Margin
Consecutive Gross Margin Decline
Key Stats
0.0000DAY`S RANGE0.0000
0.000052 WK RANGE0.0000
0.0000
0.0000
--
--
--
--
--
--
--
--
--
--
--
--
--
--
0.0000
0.0000
0.0000
0.0000
About LFVN
Lifevantage Corporation
A pioneer in nutrigenomics, the study of how nutrition and naturally occurring compounds affect human genes to support good health
Healthcare Equipment and Supplies
--
09/12/2012
NASDAQ Stock Exchange
232
06-30
Common stock
3300 N. Triumph Blvd, Suite 700, Lehi, Utah 84043
--
Lifevantage Corporation was incorporated in Colorado in June 1988 as Andraplex Corporation. In November 2006, the company changed its name to Lifevantage Corporation. In 2018, the company was re-registered from Colorado to Delaware. LifeVantage is a company focused on nutritional genomics, studying how nutrients and natural compounds affect human genes to support health. LifeVantage is dedicated to helping people achieve their health, wellness and financial goals. The company provides high-quality, scientifically proven products to clients and independent advisors, and direct sales opportunities on a commission basis to independent advisors.
Earnings Call
Company Financials
EPS
LFVN has released its 2026 Q1 earnings. EPS was reported at 0.18, versus the expected 0.19, missing expectations. The chart below visualizes how LFVN has performed over recent quarters, highlighting trends in earnings surprises.
Revenue & Expenses
LFVN has released its 2026 Q1 earnings report, with revenue of 47.56M, reflecting a YoY change of 0.73%, and net profit of 2.15M, showing a YoY change of 18.02%. The Sankey diagram below clearly presents LFVN's revenue sources and cost distribution.
Forecast
Wall Street Opinions
Price Target
Volume Profile
Trade Flow Insight
Seasonals
Community Forum
Loading...
Related News
No articles available


